S100B is downregulated in the nuclear proteome of schizophrenia corpus callosum

European Archives of Psychiatry and Clinical Neuroscience

Volumn 264, Issue 4, 2014, Pages 311-316

  Steiner, Johann ^a,b   Schmitt, Andrea ^c,d   Schroeter, Matthias L ^e,f   Bogerts, Bernhard ^a,b   Falkai, Peter ^c   Turck, Christoph W ^g   Martins De Souza, Daniel ^c,d,g,h  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Center for Behavioral Brain Sciences   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^f UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^g MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^h UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Corpus callosum; Mass spectrometry; Oligodendrocytes; Proteomics; S100B; White matter

Indexed keywords

PROTEIN S100B; PROTEOME; S100B PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN REGION; CELL MATURATION; CONTROLLED STUDY; CORPUS CALLOSUM; DOWN REGULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; NEUROPATHOLOGY; OLIGODENDROGLIA; PRIORITY JOURNAL; SCHIZOPHRENIA; VERY ELDERLY; WESTERN BLOTTING; WHITE MATTER; YOUNG ADULT; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CORPUS CALLOSUM; DOWN-REGULATION; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEOME; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SCHIZOPHRENIA;

EID: 84903643592     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-014-0490-z     Document Type: Article

References (24)

1. Bernstein HG, Steiner J, Bogerts B (2009) Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy. Expert Rev Neurother 9:1059-1071
2. Deloulme JC, Raponi E, Gentil BJ, Bertacchi N, Marks A, Labourdette G, Baudier J (2004) Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation. Mol Cell Neurosci 27:453-465 (Pubitemid 39539999)
3. Fitzsimmons J, Kubicki M, Shenton ME (2013) Review of functional and anatomical brain connectivity findings in schizophrenia. Curr Opin Psychiatry 26:172-187
4. Guo S, Kendrick KM, Zhang J, Broome M, Yu R, Liu Z, Feng J (2013) Brain-wide functional inter-hemispheric disconnection is a potential biomarker for schizophrenia and distinguishes it from depression. NeuroImage Clin 2:818-826
5. Innocenti GM, Ansermet F, Parnas J (2003) Schizophrenia, neurodevelopment and corpus callosum. Mol Psychiatry 8:261-274 (Pubitemid 36712920)
6. Jahn T, Mussgay L (1989) Die statistische Kontrolle moeglicher Medikamenteneinfluesse in experimentalpsychologischen Schizophreniestudien: Ein Vorschlag zur Berechnung von Chlorpromazina aequivalenten. Z Klin Psychol Psychother 18:10
7. Liu J, Shi Y, Tang J, Guo T, Li X, Yang Y, Chen Q, Zhao X, He G, Feng G, Gu N, Zhu S, Liu H, He L (2005) SNPs and haplotypes in the S100B gene reveal association with schizophrenia. Biochem Biophys Res Commun 328:335-341 (Pubitemid 40164673)
8. Maccarrone G, Rewerts C, Lebar M, Turck CW, Martins-de-Souza D (2013) Proteome profiling of peripheral mononuclear cells from human blood. Proteomics 13:893-897
9. Meltzer HY, Fatemi SH (1998) Treatment of schizophrenia. In: Schatzberg AF, Nemeroff CB (eds) The American psychiatric text book of psychopharmacology. American Psychiatric Press, Washington, pp 127-135
10. Mitterauer BJ (2011) Possible role of glia in cognitive impairment in schizophrenia. CNS Neurosci Ther 17:333-344
11. Rotarska-Jagiela A, Schonmeyer R, Oertel V, Haenschel C, Vogeley K, Linden DE (2008) The corpus callosum in schizo-phrenia- volume and connectivity changes affect specific regions. Neuroimage 39:1522-1532
12. Rothermundt M, Ahn JN, Jorgens S (2009) S100B in schizophrenia: an update. Gen Physiol Biophys 28 Spec No Focus, F76-81
13. Rothermundt M, Falkai P, Ponath G, Abel S, Burkle H, Diedrich M, Hetzel G, Peters M, Siegmund A, Pedersen A, Maier W, Schramm J, Suslow T, Ohrmann P, Arolt V (2004) Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry 9:897-899 (Pubitemid 39381953)
14. Rothermundt M, Peters M, Prehn JH, Arolt V (2003) S100B in brain damage and neurodegeneration. Microsc Res Tech 60:614-632
15. Schmitt A, Bertsch T, Henning U, Tost H, Klimke A, Henn FA, Falkai P (2005) Increased serum S100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms. Schizophr Res 80:305-313 (Pubitemid 41713656)
16. Schroeter ML, Abdul-Khaliq H, Krebs M, Diefenbacher A, Blasig IE (2009) Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia - original research and meta-analysis. Psychiatry Res 167:66-72
17. Steiner J, Bernstein HG, Bielau H, Berndt A, Brisch R, Mawrin C, Keilhoff G, Bogerts B (2007) Evidence for a wide extraastrocytic distribution of S100B in human brain. BMC Neurosci 8:2 (10 pages)
18. Steiner J, Bernstein HG, Bielau H, Farkas N, Winter J, Dobrowolny H, Brisch R, Gos T, Mawrin C, Myint AM, Bogerts B (2008) S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study. J Psychiatr Res 42:868-876 (Pubitemid 351787739)
19. Steiner J, Bielau H, Bernstein HG, Bogerts B, Wunderlich MT (2006) Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones. J Neurol Neurosurg Psychiatry 77:1284-1287 (Pubitemid 44654765)
20. Steiner J, Walter M, Guest P, Myint AM, Schiltz K, Panteli B, Brauner M, Bernstein HG, Gos T, Herberth M, Schroeter ML, Schwarz MJ, Westphal S, Bahn S, Bogerts B (2010) Elevated S100B levels in schizophrenia are associated with insulin resistance. Mol Psychiatry 15:3-4
21. Steiner J, Westphal S, Schroeter ML, Schiltz K, Jordan W, Muller UJ, Bernstein HG, Bogerts B, Schmidt RE, Jacobs R (2012) Increased S100B + NK cell counts in acutely ill schizophrenia patients are correlated with the free cortisol index, but not with S100B serum levels. Brain Behav Immun 26:564-567
22. Streitbürger DP, Arelin K, Kratzsch J, Thiery J, Steiner J, Villringer A, Mueller K, Schroeter ML (2012) Validating serum S100B and neuron-specific enolase as biomarkers for the human brain - a combined serum, gene expression and MRI study. PLoS ONE 7:e43284
23. Takahashi N, Sakurai T, Davis KL, Buxbaum JD (2011) Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Prog Neurobiol 93:13-24
24. Uranova NA, Vostrikov VM, Vikhreva OV, Zimina IS, Kolomeets NS, Orlovskaya DD (2007) The role of oligodendrocyte pathology in schizophrenia. Int J Neuropsychopharmacol 10:537-545 (Pubitemid 46985262)